• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMylan

Mylan

Page 5 of 6
Senator Amy Klobuchar, D-MN, listens to
Health
Lawmakers Are Demanding Investigations Into Mylan’s Huge EpiPen Price Hike
By Sy MukherjeeAugust 23, 2016
Amid debate on drug prices, California leads way on cost controls
Health
How Mylan Got Away With Its Enormous Price Hike for the EpiPen
By Sy MukherjeeAugust 22, 2016
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
Health
How Mylan Is Taking On One of the World’s Top Breast Cancer Drugs
By Sy MukherjeeJune 5, 2016
Mylan NV Chief Executive Officer Heather Bresch Interview
Finance
Here’s Why Mylan’s Stock Plunged
By Jen WiecznerFebruary 11, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health
Mylan Reaches $7.2 Billion Deal for Meda
By Laura LorenzettiFebruary 10, 2016
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
Finance
Why Mylan Just Lost The Largest Hostile Takeover Battle Ever
By Jen WiecznerNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership
Mylan, Valeant and Theranos: What the Heck, Biotech?
By Jeffrey SonnenfeldNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health
Mylan’s Hostile Bid for Perrigo Fails
By ReutersNovember 13, 2015
Mylan's Heather Bresch at the 2015 MPW Summit.
MPW
Mylan CEO Heather Bresch: We needed tax inversion in order to grow
By Jen WiecznerOctober 14, 2015
Perrigo CEO Joe Papa, right, at a charity event in 2013.
Finance
Why this pharma CEO bought his arch-rival’s stock
By Jen WiecznerSeptember 18, 2015
Blurred governance: Mylan’s illusions vs. BofA’s realities
Leadership
Blurred governance: Mylan’s illusions vs. BofA’s realities
By Jeffrey SonnenfeldSeptember 15, 2015
Heather Bresch CEO of Mylan a global pharmaceutical company
MPW
Why Wall Street loves to hate Mylan’s CEO
By Jen WiecznerSeptember 11, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Finance
This drug-industry deal would be the largest hostile takeover in history
By Jen WiecznerSeptember 8, 2015
Google/E.U. and Walmart’s holiday sales — 5 things to know today
Features
Google/E.U. and Walmart’s holiday sales — 5 things to know today
By Tom Huddleston Jr. and Geoffrey SmithAugust 28, 2015
Trader watches the screen at his terminal on the floor of the New York Stock Exchange in New York
Features
Stocks, economic growth, and a Fed conference — 5 things to know this week
By Tom Huddleston Jr.August 23, 2015
1
  • 2
  • 3
  • 4
  • 5
  • 6
6
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.